Affiliation:
1. Shengjing Hospital of China Medical University
Abstract
Abstract
Background: During the past three years of the COVID-19 pandemic, COVID-19 has been recognized to cause various neurological complications, including rare posterior reversible encephalopathy syndrome (PRES). However, it remains controversial whether infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or widely coexisting known factors of PRES such as hypertension, acute kidney injury, and the use of immunosuppressants in COVID-19 patients play the main role in the pathogenesis of PRES associated with COVID-19.
Case presentation: Here we report a case of PRES in an 18-year-old female with mild SARS-CoV-2 infection who had no known factors related to PRES. We also conducted a literature search using PubMed for similar cases of PRES associated with COVID-19 and summarized the clinical characteristics of these patients.
Conclusions: These cases strongly suggest that among the numerous factors that may trigger PRES in COVID-19, the infection itself may be one of the core factors.
Publisher
Research Square Platform LLC
Reference35 articles.
1. Neurological complications and infection mechanism of SARS-CoV-2;Wan D;Signal Transduct Target Ther,2021
2. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19);Harapan BN;J Neurol,2021
3. Posterior reversible encephalopathy syndrome (PRES) associated with COVID-19;Lallana S;J Clin Neurosci Off J Neurosurg Soc Australas,2021
4. Iftikhar S, Rehman AU, Ameer MZ, Nawaz A, Aemaz Ur Rehman M, Farooq H et al. The association of posterior reversible encephalopathy syndrome with COVID-19: A systematic review. Ann Med Surg 2012. 2021; 72: 103080.
5. Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions;Fugate JE;Lancet Neurol,2015